Christopher K. Finch

2.1k total citations
69 papers, 1.5k citations indexed

About

Christopher K. Finch is a scholar working on Pulmonary and Respiratory Medicine, Geriatrics and Gerontology and Physiology. According to data from OpenAlex, Christopher K. Finch has authored 69 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 14 papers in Geriatrics and Gerontology and 14 papers in Physiology. Recurrent topics in Christopher K. Finch's work include Pharmaceutical Practices and Patient Outcomes (14 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers) and Asthma and respiratory diseases (12 papers). Christopher K. Finch is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (14 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers) and Asthma and respiratory diseases (12 papers). Christopher K. Finch collaborates with scholars based in United States, Russia and United Kingdom. Christopher K. Finch's co-authors include Timothy H. Self, Anne M. Baciewicz, Cary R. Chrisman, Shaunta’ M. Ray, Tim Self, Justin B. Usery, Bob L. Lobo, Joyce E. Broyles, Jennifer D. Twilla and James Wheeler and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

Christopher K. Finch

61 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher K. Finch United States 18 484 344 326 244 221 69 1.5k
Kamal Sud Australia 26 340 0.7× 381 1.1× 264 0.8× 377 1.5× 131 0.6× 143 2.6k
Kearkiat Praditpornsilpa Thailand 28 247 0.5× 352 1.0× 220 0.7× 404 1.7× 234 1.1× 176 2.7k
Oscar Fernando Pavão dos Santos Brazil 25 353 0.7× 438 1.3× 491 1.5× 254 1.0× 84 0.4× 85 1.8k
Amit Gupta India 20 389 0.8× 258 0.8× 214 0.7× 443 1.8× 63 0.3× 94 2.5k
Athena F. Zuppa United States 23 247 0.5× 274 0.8× 179 0.5× 214 0.9× 102 0.5× 122 1.7k
Gregory L. Braden United States 23 908 1.9× 216 0.6× 294 0.9× 400 1.6× 86 0.4× 91 2.5k
Kriang Tungsanga Thailand 26 537 1.1× 290 0.8× 83 0.3× 329 1.3× 284 1.3× 158 2.6k
Erin F. Barreto United States 25 240 0.5× 588 1.7× 271 0.8× 309 1.3× 361 1.6× 155 2.2k
Chenghui Li United States 19 205 0.4× 160 0.5× 191 0.6× 105 0.4× 150 0.7× 119 1.3k
Samira Bell United Kingdom 22 222 0.5× 210 0.6× 363 1.1× 339 1.4× 66 0.3× 78 1.9k

Countries citing papers authored by Christopher K. Finch

Since Specialization
Citations

This map shows the geographic impact of Christopher K. Finch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher K. Finch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher K. Finch more than expected).

Fields of papers citing papers by Christopher K. Finch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher K. Finch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher K. Finch. The network helps show where Christopher K. Finch may publish in the future.

Co-authorship network of co-authors of Christopher K. Finch

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher K. Finch. A scholar is included among the top collaborators of Christopher K. Finch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher K. Finch. Christopher K. Finch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kwan, Byron H., Mohammad Murshid Alam, Jacob C. Milligan, et al.. (2025). Characterization of ORKA-001, a Novel Extended Half-life Monoclonal Antibody Targeting IL-23 for the Treatment of Psoriasis. SKIN The Journal of Cutaneous Medicine. 9(2). s527–s527. 1 indexed citations
2.
Crill, Catherine M., et al.. (2025). Faculty experiences developing and directing a novel multi-campus medication therapy management introductory pharmacy practice experience. Currents in Pharmacy Teaching and Learning. 17(7). 102362–102362.
3.
Finch, Christopher K., et al.. (2025). Projecting financial sustainability for clinical pharmacy services: An implementation science brief report. Journal of the American Pharmacists Association. 66(1). 102988–102988.
4.
5.
March, Katherine, et al.. (2021). The Hunger for Mirtazapine: A Discontinuation Syndrome. Journal of Pain & Palliative Care Pharmacotherapy. 35(2). 113–116. 1 indexed citations
6.
Acquisto, Nicole M., Craig J. Beavers, Scott Bolesta, et al.. (2021). Development and application of quality measures of clinical pharmacist services provided in inpatient/acute care settings. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4(12). 1601–1617. 14 indexed citations
7.
Bianco, Christopher, Sijin Wen, Yilin Cai, et al.. (2020). NOVEL ORAL ANTICOAGULANTS ARE SAFE AND EFFECTIVE FOR THROMBOEMBOLIC PROPHYLAXIS IN OBESE PATIENTS WITH ATRIAL FIBRILLATION. Journal of the American College of Cardiology. 75(11). 505–505. 3 indexed citations
8.
Self, Timothy H., et al.. (2014). Incorrect use of peak flow meters: are you observing your patients?. Journal of Asthma. 51(6). 566–572. 10 indexed citations
9.
Wallace, J., et al.. (2012). Peak Expiratory Flow in Bed? A Comparison of 3 Positions. Respiratory Care. 58(3). 494–497. 12 indexed citations
10.
Woods, Andrew, Justin B. Usery, Shaunta’ M. Ray, Timothy H. Self, & Christopher K. Finch. (2010). An Evaluation of Inhaled Bronchodilator Therapy in Patients Hospitalized for Non-Life-Threatening COPD Exacerbations. CHEST Journal. 138(4). 712A–712A. 1 indexed citations
11.
Finch, Christopher K., et al.. (2010). An Evaluation of Peak Expiratory Flow Monitoring: A Comparison of Sitting Versus Standing Measurements. The Journal of the American Board of Family Medicine. 23(2). 166–170. 19 indexed citations
12.
Swanson, Joseph M., et al.. (2009). Evaluation of glycemic control following discontinuation of an intensive insulin protocol. Journal of Hospital Medicine. 4(1). 28–34. 13 indexed citations
13.
Hudson, Joanna Q., et al.. (2009). Hyperkalemia‐Induced Paralysis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(10). 1270–1272. 7 indexed citations
14.
Self, Timothy H., et al.. (2005). Gender Differences in the Use of Peak Flow Meters and Their Effect on Peak Expiratory Flow. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(4). 526–530. 10 indexed citations
15.
PharmD, et al.. (2004). Drug Interactions With Azole Antifungals: Focus on Fluconazole and Itraconazole. 44(6). 874–876. 1 indexed citations
16.
Pieroni, Robert E., et al.. (2004). Anticonvulsant Hypersensitivity Syndrome: Treatment with Corticosteroids and Intravenous Immunoglobulin. Southern Medical Journal. 97(3). 319–321. 24 indexed citations
17.
Finch, Christopher K., et al.. (2004). Possible Gatifloxacin-Induced Hyperglycemia. Annals of Pharmacotherapy. 38(4). 602–605. 22 indexed citations
18.
Finch, Christopher K., et al.. (2003). Treatment of Lithium‐Induced Diabetes Insipidus with Amiloride. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(4). 546–550. 17 indexed citations
19.
Finch, Christopher K., Cary R. Chrisman, Anne M. Baciewicz, & Timothy H. Self. (2002). Rifampin and Rifabutin Drug Interactions. Archives of Internal Medicine. 162(9). 985–985.
20.
Finch, Christopher K., et al.. (2002). Fluconazole-Carbamazepine Interaction. Southern Medical Journal. 95(9). 1099–1100. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kamal Sud Breakdown of academic impact, for papers by Kearkiat Praditpornsilpa Breakdown of academic impact, for papers by Oscar Fernando Pavão dos Santos Breakdown of academic impact, for papers by Amit Gupta Breakdown of academic impact, for papers by Athena F. Zuppa Breakdown of academic impact, for papers by Gregory L. Braden Breakdown of academic impact, for papers by Kriang Tungsanga Breakdown of academic impact, for papers by Erin F. Barreto Breakdown of academic impact, for papers by Chenghui Li Breakdown of academic impact, for papers by Samira Bell
Rankless by CCL
2026